Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer

被引：0
作者：
Mohamed Hebbar
Marc Ychou
Michel Ducreux
机构：
[1] Centre Hospitalo-Universitaire,Unité d’Oncologie Médicale
[2] Val d’Aurelle Anti-Cancer Centre,Department of Digestive Oncology
[3] Gustave-Roussy Institute,Department of Digestive Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Colorectal cancer; Liver metastases; Irinotecan; UGT1A1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 752
页数：3
相关论文
共 50 条
[41]   A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients [J].
G Allegrini ;
A Falcone ;
A Fioravanti ;
M T Barletta ;
P Orlandi ;
F Loupakis ;
E Cerri ;
G Masi ;
A Di Paolo ;
R S Kerbel ;
R Danesi ;
M Del Tacca ;
G Bocci .
British Journal of Cancer, 2008, 98 :1312-1319
[42]   Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer [J].
Yang, Bing-Bing ;
Wu, Chi-Yuan ;
Chen, Eric ;
Infante, Jeffrey R. ;
Chen, Alin ;
Gao, Bing ;
Smith, Brian ;
Litten, Jason ;
Kennecke, Hagen .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03) :205-212
[43]   Combination of irinotecan and other drugs in the treatment of colorectal metastatic cancer [J].
Ducreux, M ;
Gil-Delgado, M ;
André, T ;
Ychou, M ;
de Gramond, A ;
Khayat, D .
BULLETIN DU CANCER, 1998, :43-46
[44]   A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer [J].
A. Sabharwal ;
P. G. Corrie ;
R. S. Midgley ;
C. Palmer ;
J. Brady ;
P. Mortimer ;
A. J. Watson ;
G. P. Margison ;
M. R. Middleton .
Cancer Chemotherapy and Pharmacology, 2010, 66 :829-835
[45]   A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer [J].
Sabharwal, A. ;
Corrie, P. G. ;
Midgley, R. S. ;
Palmer, C. ;
Brady, J. ;
Mortimer, P. ;
Watson, A. J. ;
Margison, G. P. ;
Middleton, M. R. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) :829-835
[46]   Clinical Pharmacokinetics of Irinotecan-Based Chemotherapy in Colorectal Cancer Patients [J].
Di Paolo, Antonello ;
Bocci, Guido ;
Danesi, Romano ;
Del Tacca, Mario .
CURRENT CLINICAL PHARMACOLOGY, 2006, 1 (03) :311-323
[47]   A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer [J].
Fornaro, Lorenzo ;
Masi, G. ;
Bursi, S. ;
Loupakis, F. ;
Vasile, E. ;
Antonuzzo, A. ;
Chiara, S. ;
Pfanner, E. ;
Di Paolo, A. ;
Bocci, G. ;
Del Tacca, M. ;
Falcone, A. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) :965-969
[48]   A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer [J].
Sato, Yasushi ;
Ohnuma, Hiroyuki ;
Hirakawa, Masahiro ;
Takahashi, Minoru ;
Osuga, Takahiro ;
Okagawa, Yutaka ;
Murase, Kazuyuki ;
Takada, Kohichi ;
Kawano, Yutaka ;
Iyama, Satoshi ;
Hayashi, Tsuyoshi ;
Sato, Tsutomu ;
Miyanishi, Koji ;
Takimoto, Rishu ;
Kobune, Masayoshi ;
Okita, Kenji ;
Mizuguchi, Toru ;
Furuhata, Tomohisa ;
Hirata, Koichi ;
Kato, Junji .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) :587-594
[49]   A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer [J].
Yasushi Sato ;
Hiroyuki Ohnuma ;
Masahiro Hirakawa ;
Minoru Takahashi ;
Takahiro Osuga ;
Yutaka Okagawa ;
Kazuyuki Murase ;
Kohichi Takada ;
Yutaka Kawano ;
Satoshi Iyama ;
Tsuyoshi Hayashi ;
Tsutomu Sato ;
Koji Miyanishi ;
Rishu Takimoto ;
Masayoshi Kobune ;
Kenji Okita ;
Toru Mizuguchi ;
Tomohisa Furuhata ;
Koichi Hirata ;
Junji Kato .
Cancer Chemotherapy and Pharmacology, 2015, 75 :587-594
[50]   A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer [J].
Lorenzo Fornaro ;
G. Masi ;
S. Bursi ;
F. Loupakis ;
E. Vasile ;
A. Antonuzzo ;
S. Chiara ;
E. Pfanner ;
A. Di Paolo ;
G. Bocci ;
M. Del Tacca ;
A. Falcone .
Cancer Chemotherapy and Pharmacology, 2009, 63 :965-969
12345